Current Report Filing (8-k)
03 December 2022 - 8:06AM
Edgar (US Regulatory)
0000837852
false
0000837852
2022-11-30
2022-11-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 30, 2022
IDEANOMICS, INC.
(Exact name of registrant as specified
in its charter)
Nevada |
20-1778374 |
(State or other jurisdiction of |
(IRS Employer |
incorporation) |
Identification No.) |
001-35561
(Commission File Number)
1441 Broadway, Suite 5116, New York, NY 10018
(Address of principal executive offices)
(Zip Code)
212-206-1216
(Registrant’s telephone number, including
area code)
N/A
(Former name or former address, if changed
since last report.)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading symbol(s) |
Name of each exchange on which registered |
Common stock, $0.001 par value per share |
IDEX |
The
Nasdaq Stock Market |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
On November 30, 2022, Ideanomics, Inc. (the “Company”)
received a letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was no
longer in compliance with the audit committee requirements as set forth in Nasdaq Listing Rule 5605, which requires the Audit Committee
of the Board of Directors of the Company (the “Audit Committee”) to be comprised of a minimum of three independent directors.
The Audit Committee is currently comprised of two independent directors and one vacancy. The Letter provides that the Company is eligible
for a cure period in which to regain compliance with Nasdaq Listing Rule 5605. This cure period will expire at the earlier of the Company’s
next annual meeting of stockholders or October 31, 2023. Alternatively, if the Company’s next annual meeting is held before May
1, 2023, then the Company must evidence compliance no later than May 1, 2023.
The Company intends to appoint an additional
independent director to the Board and the Audit Committee as soon as practicable and prior to the expiration of this cure period, but
there can be no assurance that the Company will be able to regain compliance with Nasdaq Listing Rule 5605 or maintain compliance with
any other listing requirements. The Letter has no immediate effect on the listing or trading of the Company’s common stock, which
will continue to be listed and traded on the Nasdaq Capital Market under the symbol “IDEX,” subject to the Company’s
compliance with the other Nasdaq listing requirements.
Item 9.01 Financial
Statements and Exhibits.
(d) Exhibits.
Exhibit
Number |
|
Description |
104 |
|
Cover page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Ideanomics, Inc. |
|
|
|
Date: December 2, 2022 |
By: |
/s/ Alfred P. Poor |
|
|
Alfred P. Poor |
|
|
Chief Executive Officer |
Ideanomics (NASDAQ:IDEX)
Historical Stock Chart
From Apr 2024 to May 2024
Ideanomics (NASDAQ:IDEX)
Historical Stock Chart
From May 2023 to May 2024